Detalhe da pesquisa
1.
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study.
Clin Gastroenterol Hepatol
; 22(1): 102-112.e9, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088457
2.
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study.
Clin Gastroenterol Hepatol
; 22(1): 113-123.e9, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088458
3.
The use of current knowledge and non-invasive testing modalities for predicting at-risk non-alcoholic steatohepatitis and assessing fibrosis.
Liver Int
; 43(5): 964-974, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36864668
4.
Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis.
Gastroenterology
; 160(1): 219-231.e1, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32781086
5.
A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis.
Am J Gastroenterol
; 117(11): 1805-1815, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327436
6.
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH.
Hepatology
; 73(2): 625-643, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33169409
7.
Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease.
Am J Gastroenterol
; 116(12): 2399-2409, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382947
8.
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials.
J Hepatol
; 73(1): 26-39, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147362
9.
Impact of hepatitis C virus therapy on metabolism and public health.
Liver Int
; 37 Suppl 1: 13-18, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28052632
10.
Olanzapine and benztropine as a cause of ischemic colitis in a 27-year-old man.
J Clin Gastroenterol
; 46(6): 515-7, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22011585
11.
Accuracy of Noninvasive Diagnostic Tests for the Detection of Significant and Advanced Fibrosis Stages in Nonalcoholic Fatty Liver Disease: A Systematic Literature Review of the US Studies.
Diagnostics (Basel)
; 12(11)2022 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36359453
12.
Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial.
Lancet Gastroenterol Hepatol
; 7(7): 603-616, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325622
13.
A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes.
Nat Commun
; 12(1): 5503, 2021 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34535644
14.
Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis.
Hepatol Commun
; 5(7): 1201-1211, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34278169
15.
The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease: When to Biopsy and in Whom.
Clin Liver Dis
; 22(1): 109-119, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29128050
16.
Lean Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease.
Gastroenterol Hepatol (N Y)
; 17(4): 184-186, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34035780
17.
Developing a relationship with a liver transplant program.
Clin Liver Dis (Hoboken)
; 9(3): 73-76, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30992963